US tax crackdown whacks pharma stocks
This article was originally published in Scrip
Executive Summary
The fall-out was felt in pharma stocks on 23 September when the US Treasury announced after markets closed on 22 September that it planned to introduce new guidance tightening up tax inversion and other tax avoidance measures by US corporations (scripintelligence.com, 23 September 2014).